Abstract

Interferon-induced transmembrane (IFITM) proteins are potent antiviral factors shown to restrict the infection of many enveloped viruses, including HIV. Here we report cloning and characterization of a panel of nonhuman primate IFITMs. We show that, similar to human IFITM, nonhuman primate IFITM proteins inhibit HIV and other primate lentiviruses. While some nonhuman primate IFITM proteins are more potent than human counterparts to inhibit HIV-1, they are generally not effective against HIV-2 similar to that of human IFITMs. Notably, depending on SIV strains and also IFITM species tested, nonhuman primate IFITM proteins exhibit distinct activities against SIVs; no correlation was found to support the notion that IFITM proteins are most active in non-natural primate hosts. Consistent with our recent findings for human IFITMs, nonhuman primate IFITM proteins interact with HIV-1 Env and strongly act in viral producer cells to impair viral infectivity and block cell-to-cell transmission. Accordingly, knockdown of primate IFITM3 increases HIV-1 replication in nohuman primate cells. Interestingly, analysis of DNA sequences of human and nonhuman primate IFITMs suggest that IFITM proteins have been undergoing purifying selection, rather than positive selection typical for cellular restriction factors. Overall, our study reveals some new and unexpected features of IFITMs in restricting primate lentiviruses, which enhances our understanding of virus-host interaction and AIDS pathogenesis.

Highlights

  • Following detection of pathogen-associated molecular patterns (PAMPs), cells produce and secrete interferon [1, 2]

  • While it was previously shown that Interferon-induced transmembrane (IFITM) from African green monkey (AGM) are capable of restricting both human immunodeficiency virus (HIV)-1 and SIVagm to varying degrees [49], we further sought to know if the IFITMs from additional nonhuman primates are capable of restricting HIV

  • Against HIV-1 NL4.3, we found that both human IFITM1 and IFITM3 had less than a two-fold reduction in infectivity, similar to our previous results [50], while we found up to an approximate 5- and 10-fold reduction in infectivity for the majority of nonhuman primate IFITM1 and IFITM3 tested (Fig 1A)

Read more

Summary

Introduction

Following detection of pathogen-associated molecular patterns (PAMPs), cells produce and secrete interferon [1, 2]. Interferons are cytokines that upregulate the expression of hundreds of interferon-stimulated genes (ISGs) and represent one of the cells first lines of defense against viruses [3]. The interferon-induced transmembrane (IFITM) proteins are a subset of ISGs known to restrict several enveloped viruses including, but not limited to, influenza A virus (IAV), dengue virus, Ebola virus, SARS coronavirus, hepatitis C virus (HCV), Jaagsiekte sheep retrovirus (JSRV) and human immunodeficiency virus (HIV) [12,13,14,15,16,17,18,19].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call